Yu Zhihua, Zheng Xuanlu, Wang Chenghui, Chen Chuan, Ning Na, Peng Danting, Liu Te, Pan Weidong
Shanghai Geriatric Institute of Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200031, China.
Department of Neurology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200031, China.
Evid Based Complement Alternat Med. 2022 Mar 28;2022:2200662. doi: 10.1155/2022/2200662. eCollection 2022.
Positive effects have been observed when the traditional Chinese medicine Hua Tuo Zai Zao Wan (HTZZW) has been used for the treatment of atherosclerosis (AS), although with an unclear mechanism.
ApoE-/- C57/BALB mice were used to determine the efficacy of HTZZW by blood lipid biochemical analysis and histopathology H&E staining. qPCR and western blot were used to determine the expression of METTL3/14 and NF-B.
High-fat diet-fed ApoE-/- mice that consumed HTZZW exhibited significantly smaller plaque areas and significantly decreased unstable collagen areas in the aortic arch as well as significantly lower blood levels of total cholesterol, triglycerides, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol compared with the control group. Consumption of HTZZW significantly decreased the proportion of M1 in the peripheral blood. HTZZW not only inhibited the expression of m6A methyltransferases METTL14, METTL3, and overall RNA methylation level, but it also decreased the m6A modification level on specific sites of NF-B mRNA.
HTZZW significantly alleviated the progression of AS by regulating the expression of the m6A methyltransferases METTL14 and METTL3 in macrophages, eliminating m6A modifications of NF-B mRNA, influencing the stability of NF-B mRNA, and ultimately resulting in the deactivation of inflammatory macrophages.
中药华佗再造丸(HTZZW)用于治疗动脉粥样硬化(AS)时已观察到积极效果,但其机制尚不清楚。
采用载脂蛋白E基因敲除(ApoE-/-)的C57/BALB小鼠,通过血脂生化分析和组织病理学苏木精-伊红(H&E)染色来确定HTZZW的疗效。采用实时定量聚合酶链反应(qPCR)和蛋白质免疫印迹法(western blot)来检测甲基转移酶样蛋白3/14(METTL3/14)和核因子κB(NF-κB)的表达。
与对照组相比,喂食高脂饮食并服用HTZZW的ApoE-/-小鼠主动脉弓处斑块面积显著减小,不稳定胶原区域显著减少,血液中总胆固醇、甘油三酯、高密度脂蛋白胆固醇和低密度脂蛋白胆固醇水平也显著降低。服用HTZZW显著降低了外周血中M1型细胞的比例。HTZZW不仅抑制了m6A甲基转移酶METTL14、METTL3的表达以及总体RNA甲基化水平,还降低了NF-κB mRNA特定位点的m6A修饰水平。
HTZZW通过调节巨噬细胞中m6A甲基转移酶METTL14和METTL3的表达,消除NF-κB mRNA的m6A修饰,影响NF-κB mRNA的稳定性,最终导致炎性巨噬细胞失活,显著缓解了AS的进展。